The FDA has expanded its approval of belzutifan, a new kidney cancer drug, to treat metastatic renal cancer. Learn about UT Southwestern's role, from gene discovery to drug development.
Researchers are combining experience in chemical synthesis and nanoparticle engineering with their knowledge of cancer development to design future therapies.
UT Southwestern is a leader in robotic surgery for breast, liver and pancreatic cancer removal. Learn how these procedures reduce complications and improve outcomes.